Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T16:47:09.198Z.
Calculation as of: 2026-10-06T16:47:09.198Z.
Quote observation: 2026-10-06T16:19:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47abfa0c1c9b7ee8852b85727c09e566e291b91d06fb52154cb7b2e7f04347a4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$648.78M
EV/Sales Ratio
N/A
| NAME | MARKET CAP | EV/SALES RATIO |
|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $648.78M | N/A |
| New Mountain Finance Corporation (NMFC)vs › | $649.36M | N/A |
| Capital Bancorp, Inc. (CBNK)vs › | $651.04M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $652.97M | N/A |
| ACNB Corporation (ACNB)vs › | $653.82M | N/A |
| Chaince Digital Holdings Inc. (CD)vs › | $640.71M | N/A |
| Coastal Financial Corporation (CCB)vs › | $636.18M | N/A |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $633.97M | N/A |
| Root, Inc. (ROOT)vs › | $664.86M | N/A |
| Hypoport SE (HYPOF)vs › | $630.67M | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
